Literature DB >> 9682846

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

K Wakabayashi1, M Yoshimoto, S Tsuji, H Takahashi.   

Abstract

Lewy bodies in Parkinson' s disease (PD) are strongly immunoreactive with antibodies against alpha-synuclein, which is mutated in some familial cases of the disease. We carried out immunohistochemical examinations of the brains of multiple system atrophy (MSA) patients using anti-alpha-synuclein antibodies. Strong alpha-synuclein immunoreactivity was found in glial cytoplasmic inclusions (GCIs), which are of oligodendroglial origin and occur exclusively in MSA. Alpha-synuclein-immunoreactive neuronal cytoplasmic inclusions (NCIs) were also found occasionally in the substantia nigra, pontine and inferior olivary nuclei, and dentate fascia. These findings indicate that alpha-synuclein is also a major component of GCIs and NCIs in MSA and strongly suggest that alpha-synuclein aggregation is a common process in certain neurodegenerative diseases, including PD and MSA.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9682846     DOI： 10.1016/s0304-3940(98)00407-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  190 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

Authors:  L C Serpell; J Berriman; R Jakes; M Goedert; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 3.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding.

Authors:  Tim Bartels; Logan S Ahlstrom; Avigdor Leftin; Frits Kamp; Christian Haass; Michael F Brown; Klaus Beyer
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 5.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

Review 6.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 7.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

8.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway.

Authors:  Yuhe Yuan; Jin Jin; Bo Yang; Wei Zhang; Jinfeng Hu; Yun Zhang; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

10.  Adsorption and decontamination of α-synuclein from medically and environmentally-relevant surfaces.

Authors:  Hanh T M Phan; Jason C Bartz; Jacob Ayers; Benoit I Giasson; Mathias Schubert; Keith B Rodenhausen; Negin Kananizadeh; Yusong Li; Shannon L Bartelt-Hunt
Journal:  Colloids Surf B Biointerfaces       Date:  2018-03-09       Impact factor: 5.268
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.